SCHEMBL3840862

SCHEMBL3840862

O=C(O)Oc1c(SC2CCC(C(=O)O)CC2)nc(-c2ccco2)n1Cc1cc2c(cc1Cl)OCO2

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 1/20 0.44
ADORA2A P29274 1/20 0.38
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
KDM4E B2RXH2 2/20 0.34
VCP P55072 1/20 0.33
MCHR1 Q99705 1/20 0.33
KMT2A Q03164 1/20 0.32
NPC1 O15118 1/20 0.32
TSHR P16473 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32
KDR P35968 1/20 0.32
SLC22A12 Q96S37 1/20 0.31
CYP3A4 P08684 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3839272 0.91 EDNRA (0.55) EDNRAADORA2AALDH1A1HPGDSMN1; SMN2
SCHEMBL3836687 0.88 EDNRA (0.54) EDNRAADORA2AALDH1A1HPGDSMN1; SMN2
SCHEMBL3834407 0.81 EDNRA (0.64) EDNRAALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL8597314 0.80 ADORA2A (0.44) EDNRAADORA2AALDH1A1HPGDSMN1; SMN2
SCHEMBL3839270 0.79 EDNRA (0.68) EDNRAADORA2AALDH1A1HPGDSMN1; SMN2
SCHEMBL3835789 0.72 EDNRA (0.58) EDNRAALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL3834962 0.72 EDNRA (0.58) EDNRAALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL3839183 0.72 EDNRA (0.78) EDNRAALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL7501806 0.71 EDNRA (0.57) EDNRAALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL3839302 0.70 EDNRA (0.56) EDNRAALDH1A1HPGDSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0861247-B1 NOVEL IMIDAZOLE N-BENZYLDIOXOL DERIVATIVES, METHOD FOR PREPARING SAME, RESULTING INTERMEDIATES, PHARMACEUTICAL COMPOSITIONS AND USE OF SAID DERIVATIVES AS ENDOTHELIN ANTAGONISTS AVENTIS PHARMA SA (FR) 2009-10-07 EP claimed